POZ - Women Hub : Treatment News

POZ Women / Female Hub
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Women's Hub News

Back to home » News & Views » Treatment News

February 29, 2008
GSK Comments on ACTG 5202 Study Changes
HIV Treatment Increases Survival, Not Heart Attack Risk
February 28, 2008
Epzicom Efficacy Concerns Lead to ACTG Study Changes
February 27, 2008
Safe for Some to Switch to Viramune With Higher CD4 Counts
February 26, 2008
New Prezista 600 mg Tablet Approved
GeoVax Vaccine to Move Forward
February 25, 2008
Growth Hormone Boosts Thymus T-Cell Production
February 22, 2008
Discordant Responders Have Faster Disease Progression
February 21, 2008
Drug Use Linked to Infection With Resistant Virus
February 20, 2008
Dipstick Kidney Test Less Accurate in HIV
Study Links Zerit and Retrovir With Diabetes Risk
February 19, 2008
Starting Treatment With Higher CD4s Cuts Death Rate
February 15, 2008
HIV Treatment Improves, but Doesn’t Restore, B Cells
February 14, 2008
Suppressing HIV Improves Kidney Function
February 13, 2008
Acyclovir Doesn’t Reduce HIV Infection Risk in HSV-2-Positive People
February 12, 2008
Extended-Release Viramune Begins Study
VIRxSYS Gene Therapy Makes Progress
Women & HIV Treatment
World of Prevention: Vaccines and More
Condom-Free Sex? Controversial Swiss Declaration
February 11, 2008
New Hope for Treatment Experienced
February 09, 2008
Good Bacteria Reduces Vaginal HIV Levels
February 08, 2008
HIV & Your Heart: Part I
HIV & Your Heart: Part II
Morris Jackson: Survivor and Treatment Activist
February 07, 2008
Prevention and Women: HIV-positive and HIV-negative
Once-Daily Viramune Is at Least as Efficient as Twice-Daily Dosing
Durable Efficacy Seen in Studies of New NNRTI Intelence
Nanotechnology May Yield Long-Lasting Meds
February 06, 2008
Male Circumcision Doesn't Reduce Women's HIV Risk
TDM-Guided PI Dose Increases of Limited Benefit
Refining HIV Treatment for New Med Takers
February 05, 2008
AIDS Survival: Progress Not Perfection
Once- vs. Twice-Daily Kaletra Tablets: Similar Safety and Potency
Epzicom Comparable to Truvada as First-Line NRTI Choice
February 04, 2008
Vicriviroc Shows Well in Treatment-Experienced Patients
Abacavir, Didanosine Linked to Increased Heart Attack Risk
Norvir/Reyataz Comparable to Kaletra for First-Line Therapy
Sexual Reinfection With HCV Following Treatment
February 01, 2008
Parasitic Drug Shows HIV-Fighting Promise
Gilead Loses Key Patents on Tenofovir


Featured Video
Participants share their stories at the XIX International AIDS Conference. For more on the conference, click here.
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

    San Francisco


    San Francisco

    el dorado
Click here to join POZ Personals!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.